慢性阻塞性肺疾病急性加重的诊治进展

doi:10.3969/j.issn.1002-1949.2019.05.018

摘要
图/表
参考文献(26)
相关文章 (13)

全文: PDF (638 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要慢性阻塞性肺疾病(chronic obstructive pulmonary disease， COPD)是一种严重危害人类健康的常见病，而慢性阻塞性肺疾病急性加重(acute exacerbation of chronic obstructive pulmonary disease， AECOPD)会对患者的生活质量、疾病进程和社会经济负担带来严重的负面影响。因此，全面了解AECOPD各方面概况，对科学认识和规范治疗AECOPD意义重大。本文结合相关文献和指南，从AECOPD的概述、病原学和诊治三个方面进行阐述，旨在帮助临床医师更好地开展AECOPD的管理工作。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	吴林
	尹文

关键词 ：慢性阻塞性肺疾病（COPD）, 慢性阻塞性肺疾病急性加重（AECOPD）, 概述, 病原学, 诊治

通讯作者: 尹文(1965-），男，主任医师，博士生导师，硕士，主治医师，E-mail: xjyyyw@126.com。

作者简介: 吴林（1978-），硕士，主治医师，E-mail: wulin501016@163.com。

引用本文:

吴林，尹文. 慢性阻塞性肺疾病急性加重的诊治进展[J]. 中国急救医学, 2019, 39(5): 486-490.

链接本文:

http://www.cnemergency.org.cn/CN/10.3969/j.issn.1002-1949.2019.05.018 或 http://www.cnemergency.org.cn/CN/Y2019/V39/I5/486

［1］慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组.慢性阻塞性肺疾病急性加重 (AECOPD)诊治中国专家共识(2017年更新版)［J］. 国际呼吸杂志， 2017， 37(14):1041-1057. ［2］Pizzini A, Filipiak W, Wille J, et al. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease［J］. J Breath Res, 2018,12(3):036002. ［3］Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management,and prevention of chronic obstructive pulmonary disease, 2018, report.  ［4］Anthonisen NR, Manfreda J, Warren CP, et al.Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease［J］. Ann Intern Med, 1987, 106(2):196-204. ［5］Tsai CL, Sobrino JA, Camargo CA Jr. National study of emergency department visits for acute exacerbation of chronic obstructive pulmonary disease, 1993-2005［J］. Acad Emerg Med, 2008, 15(12):1275-1283. ［6］Hasegawa K, Tsugawa Y, Tsai CL, et al. Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease［J］. Respir Res, 2014, 15:40. ［7］Tsai CL, Delclos GL, Camargo CA Jr. Emergency department case volume and patient outcomes in acute exacerbations of chronic obstructive pulmonary disease［J］. Acad Emerg Med, 2012, 19(6):656-663. ［8］钱传云,李涛.AECOPD急诊抗菌治疗略谈［J］. 中国急救医学， 2013, 33(10):865-868. ［9］苏盛通,陈惠业.常见苛养菌培养的研究进展［J］. 中国病原生物学杂志， 2010， 3:221-224. ［10］Lode H, Allewelt M, Balk S, et al. A prediction model for bacterial etiology in acute exacerbations of COPD［J］. Infection, 2007, 35(3):143-149. ［11］Miravitlles M, Anzueto A. Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease［J］. Am J Respir Crit Care Med, 2013, 188(9):1052-1057. ［12］邓朝胜，陈美云，林其昌，等.肺炎支原体感染对老年慢性阻塞性肺疾病急性发作及肺炎患者免疫功能的影响［J］. 中华老年医学杂志， 2004， 23(7):472-474. ［13］Hao Y, Kuang Z, Jing J, et al. Mycoplasma pneumoniae modulates STAT3-STAT6 /EGFR-FOXA2 signaling to induce overexpression of airway mucins［J］. Infect Immun, 2014, 82(12):5246-5255. ［14］Shima K, Coopmeiners J, Graspeuntner S, et al. Impact of microe-nvironmental changes on respiratory tract infections with intracellular bacteria［J］. FEBS Lett, 2016, 590(21):3887-3904. ［15］Molyneaux PL, Mallia P, Cox MJ, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease［J］. Am J Respir Crit Care Med, 2013, 188(10):1224-1231. ［16］Wilkinson TMA, Aris E, Bourne S, et al. A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD［J］. Thorax, 2017, 72(10):919-927. ［17］Yang QF, Lu TT, Shu CM, et al. Eosinophilic biomarkers for detection of acute exacerbation of chronic obstructive pulmonary disease with or without pulmonary embolism［J］. Exp Ther Med, 2017, 14(4):3198-3206. ［18］Lin C, Pang Q. Meta-analysis and systematic review of procalcitonin-guided treatment in acute exacerbation of chronic obstructive pulmonary disease［J］. Clin Respir J, 2018, 12(1):10-15. ［19］戴然然.慢性阻塞性肺疾病急性加重的治疗策略:2017欧洲呼吸学会/美国胸科学会指南解读［J］. 世界临床药物, 2017, 38(9):577-581. ［20］Wedzicha JA Ers Co-Chair, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations:a European Respiratory Society/American Thoracic Society guideline［J］. Eur Respir J, 2017, 49(3):pii1600791. ［21］Rothberg MB, Pekow PS, Lahti M, et al. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease［J］. JAMA, 2010, 303(20):2035-2042. ［22］Yang IA, Brown JL, George J, et al. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update［J］. Med J Aust, 2017, 207(10):436-442. ［23］Yoshinosuke F, Hisamichi A, Nobuyuki H, et al. The Japanese Respiratory Society guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease［J］. Nihon Kokyuki Gakkai Zasshi, 2004, Suppl:1-137. ［24］中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)［J］. 中华结核和呼吸杂志， 2013， 36(4):484-491. ［25］Prins HJ, Duijkers R, Lutter R, et al. Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD［J］. Respir Med, 2017, 131:118-124. ［26］Bathoorn E, Groenhof F, Hendrix R, et al. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care［J］. Int J Chron Obstruct Pulmon Dis, 2017, 12:285-290.